ANI Pharmaceuticals, Inc.
ANIP · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Feb 2026
Open the dashboardInfographicSummary
FY2025 key figures
| $ | FY2025 | FY2024 | Change |
|---|---|---|---|
| Revenue | $883M | $614M | +43.8% |
| Operating income | $111M | $580K | +19,053% |
| Net income | $77.2M | −$20.1M |
Latest quarter: Q3 2026
Form 10-Q · Three months ended Sep 30, 2026 · filed Nov 5, 2026
| $ | Q3 2026 | Year earlier | Change |
|---|---|---|---|
| Revenue | $291M | $228M | +27.7% |
| Operating income | $52.4M | $36.2M | +44.8% |
| Net income | $35.1M | $26.6M | +32.0% |
Q3 2026 dashboardQ3 2026 infographic
Questions
- What was ANI Pharmaceuticals's revenue in FY2025?
- $883M in FY2025 (Fiscal year ended Dec 31, 2025), +43.8% vs $614M a year earlier, per its 10-K filed Feb 2026.
- Was ANI Pharmaceuticals profitable in FY2025?
- Yes: net income was $77.2M and operating income $111M in FY2025.
- What was ANI Pharmaceuticals's revenue in Q3 2026?
- $291M (+27.7% vs a year earlier), per its Form 10-Q filed Nov 5, 2026.